financetom
Business
financetom
/
Business
/
Masimo smartwatches infringe Apple design patents, US jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo smartwatches infringe Apple design patents, US jury says
Nov 3, 2024 12:04 PM

Oct 25 (Reuters) - Apple ( AAPL ) convinced a federal

jury on Friday that health monitoring tech company Masimo's ( MASI )

smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple ( AAPL ) that Masimo's ( MASI ) W1

and Freedom watches and chargers willfully violated Apple's ( AAPL )

patent rights in smartwatch designs, awarding the tech giant

$250 in damages. Apple's ( AAPL ) attorneys told the court the "ultimate

purpose" of its lawsuit was to win an injunction against sales

of Masimo's ( MASI ) smartwatches after an infringement ruling.

The jury also determined that Masimo's ( MASI ) watches did not

infringe Apple ( AAPL ) patents covering smartwatch inventions that the

tech giant had accused Masimo ( MASI ) of copying.

Masimo ( MASI ) said in a statement that the company appreciated the

jury's verdict "in favor of Masimo ( MASI ) and against Apple ( AAPL ) on nearly

all issues," and that the decision only applied to a

"discontinued module and charger."

"Apple ( AAPL ) primarily sought an injunction against Masimo's ( MASI )

current products, and the jury's verdict is a victory for Masimo ( MASI )

on that issue," Masimo ( MASI ) said.

Apple ( AAPL ) said in a statement that it was "glad the jury's

decision today will protect the innovations we advance on behalf

of our customers."

Irvine, California-based Masimo ( MASI ) accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology

after discussing a potential collaboration. Masimo ( MASI ) convinced the

U.S. International Trade Commission last year to block imports

of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches after the

commission found that their technology for reading blood oxygen

levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has appealed the decision and resumed selling the

watches after removing the technology. The tech giant

countersued Masimo ( MASI ) for patent infringement in 2022, alleging

that Masimo ( MASI ) copied Apple Watch features to use in its

smartwatches.

Apple ( AAPL ) also accused Masimo ( MASI ) of using lawsuits at the ITC

and in California to "make way for Masimo's ( MASI ) own watch." Masimo ( MASI )

said Apple's ( AAPL ) patent lawsuit was "retaliatory" and "an attempt to

avoid the court in which the parties have been litigating their

dispute."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lyft inks deals with Mobileye, others to bring robotaxis to ridehail platform
Lyft inks deals with Mobileye, others to bring robotaxis to ridehail platform
Nov 9, 2024
(Reuters) - Lyft ( LYFT ) said on Wednesday it will partner with Mobileye and two other companies in the robotaxi industry to bring self-driving cars onto its ridehail platform and bolster research and development in the sector. The app-based taxi platform will incorporate cars owned by third-party fleet operators, equipped with the Mobileye Drive self-driving system, as it looks...
Facing tariff threat, Europe eyes options to appease Trump
Facing tariff threat, Europe eyes options to appease Trump
Nov 9, 2024
BRUSSELS (Reuters) - The European Union is considering options to appease Donald Trump on his return to the White House as it braces for a resumption of U.S. tariffs and other trade threats plus tough exchanges on how to treat China. Trump warned shortly before his U.S. presidential victory that the 27-nation bloc will have to pay a big price...
CVS Health Logs Third-Quarter Revenue Beat to Help Offset Earnings Decline
CVS Health Logs Third-Quarter Revenue Beat to Help Offset Earnings Decline
Nov 9, 2024
09:05 AM EST, 11/06/2024 (MT Newswires) -- CVS Health ( CVS ) reported mixed third-quarter results on Wednesday as earnings declined and trailed market estimates, while revenue increased and topped analyst expectations. The healthcare company posted adjusted earnings of $1.09 per share for the September quarter, down from $2.21 the year before and trailing the Capital IQ-polled consensus of $1.46....
Cencora bolsters specialty business with $4.6 bln deal for Retina Consultants of America
Cencora bolsters specialty business with $4.6 bln deal for Retina Consultants of America
Nov 9, 2024
Nov 6 (Reuters) - Cencora ( COR ) will buy Retina Consultants of America from private-equity firm Webster Equity Partners for $4.6 billion, the drug distributor said on Wednesday, beefing up its presence in the market for specialty medicines. Higher margins and growing U.S. demand for medicines that treat complex conditions such as rheumatoid arthritis and cancer have encouraged Cencora...
Copyright 2023-2026 - www.financetom.com All Rights Reserved